基于药基因组的GWAS元分析与遗传和表观遗传责任测试相结合,将面部和情感识别系统与频谱障碍,精神分裂症,抑郁症和焦虑症联系起来
Kenneth Blum1,2,3,4, Alexander P L Lewandrowski3,5, Alireza Sharafshah6
1Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel 40700, Israel.
Current pharmaceutical biotechnology
|March 14, 2026
概括
面部和情绪识别系统通过药物基因组学和全基因组关联研究与频谱障碍和心理健康状况联系在一起. 这项研究确定了ADHD,自闭症,精神分裂症和抑郁症等疾病的关键基因和治疗点.
科学领域:
- 基因组学就是基因组学.
- 药物基因组学 药物基因组学
- 人工智能的人工智能
背景情况:
- 面部和情绪识别系统 (FERS) 使用人工智能和机器学习来从各种输入中解释人类的情绪.
- 这些系统可以将情绪状态与表观遗传特征联系起来.
研究的目的:
- 研究面部和情感识别系统的遗传基础.
- 通过先进的遗传分析,探索FERS与各种神经和精神疾病之间的联系.
主要方法:
- 进行了整合药物基因组学 (PGx) 和全基因组关联研究 (GWAS) 的元元分析.
- 利用了10个GWAS数据集,通过蛋白质-蛋白质相互作用 (PPI) 等in silico分析精制基因列表.
- 应用基于PGx的方法来识别最终基因清单 (FGL) 中的显著药物基因.
主要成果:
- 确定了586个基因的二次基因列表 (SGL),改进为141个基因的最终基因列表 (FGL).
- 在FGL中发现了54种药基因 (PGx-FGL) 具有重要的注释.
- 突出了DRD2和BDNF作为具有显著表型作用的关键基因.
结论:
- 通过基于PGx的GWAS将面部和情绪识别系统连接到频谱障碍 (ADHD,自闭症),精神分裂症,抑郁症和焦虑症.
- 研究结果表明,在这些条件下,可能会出现新的治疗向.
- 强调需要进一步临床验证和支持这些发现.
相关概念视频
Human Genetics
1.8K
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
1.8K
Genome-wide Association Studies-GWAS
16.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.5K
Pharmacogenomics: Identification of New Drug Targets
73
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73
Pharmacogenetics and Pharmacogenomics: Overview
122
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
122
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
94
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
94
Principles of Pharmacogenetics: Types of Genetic Variants
73
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
73


